SAIDS 2015_01 Zanmare Terblanche vs SAIDS - Appeal

Related case:
SAIDS 2015_01 SAIDS vs Zanmare Terblanche
December 22, 2015

On 22 September 2015 the SAIDS Anti-Doping Hearing Panel decided to impose a 4 year period of ineligibility on the cyclist Zanmare Terblanche after her sample tested positive for the prohibited substance Metandienone. The Athlete failed to file a statement in her defence nor did she attend the hearing of the Anti-Doping Hearing Panel.

Hereafter in April 2016 the Athlete appealed the decision of the Anti-Doping Hearing Panel with the SAIDS Anti-Doping Appeal Tribunal.
The Athlete accepted the test results, argued that the violation was not intentional and that there are grounds for a reduced sanction. She explained that she suffered from overweight and in order to loose weight she had purchased on the internet a product Extreme Lava she thought was a fat burner. She asserted that previously she had not received any education around doping issues and was totally unaware of the existence of SAIDS and WADA or the Rules.

The Appeal Tribunal accepted the Athlete’s explanation and that the violation was not intentional.
Therefore the SAIDS Anti-Doping Appeal Tribunal decides on 3 May 2016 to annul the sanction of 4 years and to impose a 2 year period of ineligiblility on the Athlete starting on the date of the provisional suspension, i.e. on 30 April 2015.

Original document

Parameters

Legal Source
National Decisions
Date
3 May 2016
Arbitrator
Abercrombie, Alex
Gaoraelwe, Rebaone
Jakoet, Ismail
Original Source
South African Institute for Drug-Free Sport (SAIDS)
Country
South Africa
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
No intention to enhance performance
Period of ineligibility
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Cycling South Africa (CSA)
South African Institute for Drugfree Sport (SAIDS)
Laboratories
Bloemfontein, South Africa: South African Doping Control Laboratory
Doping classes
S1. Anabolic Agents
Substances
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Medical terms
Treatment / self-medication
Various
Supplements
Document type
Pdf file
Date generated
1 March 2018
Date of last modification
21 June 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin